posted
News just out! Amarin Announces Grant of Patent in the United States for Miraxion in Huntington's Disease Wednesday October 11, 9:54 am ET
Posts: 85 | From: EU | Registered: Feb 2006
| IP: Logged |
posted
Amarin Announces Grant of Patent in the United States for Miraxion in Huntington's Disease Wednesday October 11, 9:54 am ET
LONDON, October 11 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN - News) today announces that the United States Patent and Trademark Office has granted approval for its patent application covering the use of its proprietary ultra-pure ethyl-EPA compound ("Miraxion") in Huntington's disease. The patent, number 7,119,118, will run to 2021
Posts: 85 | From: EU | Registered: Feb 2006
| IP: Logged |